LEPEDDA, Antonio Junior
 Distribuzione geografica
Continente #
NA - Nord America 2.094
EU - Europa 1.228
AS - Asia 789
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 9
SA - Sud America 8
Totale 4.142
Nazione #
US - Stati Uniti d'America 2.082
UA - Ucraina 513
CN - Cina 490
IT - Italia 240
SG - Singapore 238
DE - Germania 178
FI - Finlandia 82
FR - Francia 78
SE - Svezia 52
GB - Regno Unito 35
TR - Turchia 29
KR - Corea 17
BE - Belgio 15
EU - Europa 13
CA - Canada 11
AU - Australia 8
BR - Brasile 7
DK - Danimarca 7
GR - Grecia 5
CZ - Repubblica Ceca 4
IN - India 3
NL - Olanda 3
HR - Croazia 2
IL - Israele 2
IR - Iran 2
JP - Giappone 2
LU - Lussemburgo 2
RO - Romania 2
RU - Federazione Russa 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
ES - Italia 1
HU - Ungheria 1
ID - Indonesia 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.142
Città #
Chandler 559
Jacksonville 322
Singapore 194
Princeton 174
Nanjing 133
New York 121
Sassari 116
Ann Arbor 82
Wilmington 79
Dearborn 69
Nanchang 59
Beijing 49
Boardman 44
Shenyang 32
Changsha 31
Hebei 29
Santa Clara 29
Tianjin 28
Woodbridge 28
Izmir 25
Ashburn 21
Jiaxing 21
Seoul 17
Kunming 16
Brussels 15
Zhengzhou 15
Mountain View 14
Andover 13
Hangzhou 13
Ningbo 13
Villiers-sur-marne 13
Norwalk 12
San Francisco 12
Jinan 11
Toronto 9
Guangzhou 7
Ficarazzi 6
Oristano 6
Auburn Hills 5
Dallas 5
Helsinki 5
Brno 4
Changchun 4
London 4
Los Angeles 4
Pátrai 4
Shanghai 4
Verona 4
Falls Church 3
Florence 3
Hanover 3
Lanzhou 3
Melbourne 3
Molfetta 3
Rome 3
Taizhou 3
Ardabil 2
Augusta 2
Bangkok 2
Cagliari 2
Canberra 2
Fairfield 2
Fuzhou 2
Luxembourg 2
Munich 2
Paris 2
Qingdao 2
Romola 2
Serramanna 2
Shenzhen 2
Tappahannock 2
Turin 2
Zagreb 2
Adelaide 1
Almere Stad 1
Americo Brasiliense 1
Amsterdam 1
Bratislava 1
Brierley Hill 1
Budapest 1
Buffalo 1
Cedar Knolls 1
Chernihiv 1
Chieti 1
Chisinau 1
Città Di Castello 1
Delhi 1
Denver 1
Douglas 1
Edmonton 1
Fazenda Rio Grande 1
Frankfurt am Main 1
Haifa 1
Harrow 1
Hefei 1
Istanbul 1
Latham 1
Lima 1
Logan 1
Media 1
Totale 2.565
Nome #
Natural collagenic skeleton of marine sponges in pharmaceutics: Innovative biomaterial for topical drug delivery 86
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 77
Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes 75
A poly-L-lactic acid/ collagen/glycosaminoglycan matrix for tissue engineering applications 75
A novel LIF-CE method for the separation of hyaluronan- and chondroitin sulfate-derived disaccharides: Application to structural and quantitative analyses of human plasma low- and high-charged chondroitin sulfate isomers 74
Short-end injection capillary electrophoresis for quantification of plasma chondroitin sulfate isomer disaccharides 73
Impact of first trimester fasting glycemic levels on expression of proteoglycans in pregnancy 70
A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. IF 2009: 4.522 JCR: Q1 70
Glycosaminoglycan and transforming growth factor beta1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy. IF 2009: 3.970 JCR: Q1 68
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-g (MIG) 66
Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus 66
Glycosaminoglycan and transforming growth factor beta 1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy 66
Analysis of changes in tyrosine and serine phosphorylation of red cell membrane proteins induced by P. falciparum growth 65
Plasma PP13, urinary GAGs/PGs as early markers of pre-eclampsia 64
Significance of urinary glycosaminoglycans/proteoglycans in the evaluation of type 1 and type 2 diabetes complications 63
Glycosaminoglycan functionalization of electrospun scaffolds enhances Schwann cell activity 61
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoing carotid endarterectomy 59
Oxidative Modifications in Advanced Atherosclerotic Plaques: A Focus on In Situ Protein Sulfhydryl Group Oxidation 57
Differential distribution of structural components and hydration in aortic and pulmonary heart valve conduits: Impact of detergent-based cell removal. IF 2010: 4.824 JCR: Q1 56
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 56
Content and distribution of glycosaminoglycans/proteoglycans in human thoracic aortic aneurysm 56
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 55
Protein sulfhydryl group oxidation and mixed-disulfide modifications in stable and unstable human carotid plaques 54
Association between human plasma chondroitin sulphate isomers and carotid atherosclerotic plaque 54
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 54
Differential proteomic analysis of human atherosclerotic plaque extracts 53
Identification and characterization of biomarkers in atherosclerosis and diabetes. 53
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-γ (MIG). 52
Sequence variability of apolipoprotein E gene in Corsico-Sardinian ovines 50
Structural analysis of glycosaminoglycans and proteoglycans from fresh porcine aortic valves 50
Apolipoprotein Profiles in Atherosclerotic Disease 49
Role of the small proteoglycan bikunin in human reproduction 49
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 49
Apolipoprotein Profiles in Atherosclerotic Disease 49
Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis 49
Applications of two-dimensional electrophoresis technology to the study of atherosclerosis 49
Protein oxidation in unstable plaque extracts from human carotid segments 48
Apolipoprotein profiles in atherosclerotic disease 48
A proteomic approach to identify circulating or tissue biomarkers of atherosclerosis 47
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 47
Structural analisys of plasma glycosaminoglycans in patients with atheromatous lesions 47
GAG content and distribution in porcine aortic valve tissue and in acellular pericardium scaffolds from three mammal species 45
Proteomic analysis of differential protein expression and post-translational modifications in human atherosclerotic plaques 45
Structural analysis of glycosaminoglycans from fresh porcine aortic valves 45
Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes 45
Ultrasensitive Capillary Zone Electrophoresis (CZE) for glycosaminoglycan analisys in normal human plasma 45
Evidence for a pro-oxidant environment in atherosclerotic plaques from human carotid segments 43
Plasma Levels of C-Reactive Protein, Leptin and Glycosaminoglycans During Spontaneous Menstrual Cycle: Differences Between Ovulatory and Anovulatory Cycles 43
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoingcarotid endarterectomy 43
Influencing chondrogenic differentiation of human mesenchymal stromal cells in scaffolds displaying a structural gradient in pore size 43
Apolipoprotein profiles in atherosclerotic disease 43
Human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 43
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-ϒ (MIG) 43
Tuning Cell Differentiation into a 3D Scaffold Presenting a Pore Shape Gradient for Osteochondral Regeneration 43
A Collagen-GAG synthetic extracellular matrix entrapped into PLLA polymeric scaffolds. 42
QUANTITATIVE AND STRUCTURAL ANALYSES OF URINARY TRYPSIN INHIBITOR IN TYPE 1 AND TYPE 2 DIABETES 41
Proteomic study of differential protein expression in stable and unstable human atherosclerotic plaque 40
Glycosaminoglycan content and distribution in human normal and varicose veins 40
Development of a method for urine bikunin/urinary trypsin inhibitor (UTI) quantitation and structural characterization: Application to type 1 and type 2 diabetes 40
Urine bikunin as a marker of renal impairment in Fabry's disease 40
Gradients in pore size enhance the osteogenic differentiation of human mesenchymal stromal cells in three-dimensional scaffolds 40
New Capillary Zone Electrophoresis (CZE) method for glycosaminoglycan analysis 40
Human serum albumin Cys34 oxidative modifications after infiltration in the carotid atherosclerotic plaque 39
Protein sulfhydryl-groups oxidation in stable and unstable human carotid plaques 38
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 36
Overview of Current Proteomic Approaches for Discovery of Vascular Biomarkers of Atherosclerosis 36
Protein sulfhydryl-group oxidation in stable and unstable human carotid plaques 36
GLYCOSAMINOGLYCAN DIVERSITY IN MARINE SPONGE EXTRACELLULAR MATRIX 35
Glycosaminoglycans and fabry’s disease 35
Fine structure of glycosaminoglycans from fresh and decellularized porcine cardiac valves and pericardium 35
Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles 34
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 33
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 32
Proteomic study of differential protein expression in stable and unstable human atherosclerotic plaque 32
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 32
Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 31
Structural analysis of plasma glycosaminoglycans in patients undergoing carotid endarterectomy 30
Apolipoprotein signature of hdl and ldl from atherosclerotic patients in relation with carotid plaque typology: A preliminary report 30
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients 30
Structural analysis of glycosaminoglycans from fresh porcine aortic valves 29
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 29
Urine Bikunin Quantitation and Structural Characterization in Type I and Type II Diabetes Patients 29
Circulating Heparan Sulfate Proteoglycans as Biomarkers in Health and Disease 27
Proteomic analysis of plasma-purified VLDL, LDL and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 27
Morphological and biochemical traits of target marine sponges 26
Glycosaminoglycans: From Vascular Physiology to Tissue Engineering Applications 23
Glycosaminoglycan diversity in marine sponge extracellular matrix 22
Circulating Proteoglycans/Glycosaminoglycans as Cancer Biomarkers 21
Purification of an Acidic Polysaccharide with Anticoagulant Activity from the Marine Sponge Sarcotragus spinosulus 20
A Method for Urinary Trypsin Inhibitor (UTI) Purification Combining Anion-Exchange Chromatography Enrichment and Preparative SDS-PAGE 18
Molecular Characterization of Plasma HDL, LDL, and VLDL Lipids Cargos from Atherosclerotic Patients with Advanced Carotid Lesions: A Preliminary Report 17
Urine bikunin and kidney involvement in Fabry disease 17
Searching for Atherosclerosis Biomarkers by Proteomics: A Focus on Lesion Pathogenesis and Vulnerability 13
Molecular and pathobiological insights of bikunin/UTI in cancer 12
Totale 4.205
Categoria #
all - tutte 22.614
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.614


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020510 0 0 0 0 90 63 123 9 94 32 97 2
2020/2021604 84 6 93 6 85 13 84 4 110 93 16 10
2021/2022477 53 3 3 11 10 2 25 31 63 34 56 186
2022/2023996 94 82 10 185 112 157 0 122 163 13 40 18
2023/2024359 49 25 7 12 83 76 14 8 9 11 36 29
2024/2025333 19 23 155 43 93 0 0 0 0 0 0 0
Totale 4.205